The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).
The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.
Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.
Dai Y., Aizenbud L., Qin K. et al. Nature. 644: 527–536 . (2025).
doi: 10.1038/s41586-025-09188-4.
Summary of the findings
Future impact
These findings open several promising directions. Because AAbs effectively act as naturally occurring biologic drugs, the targets they highlight can serve as a shortlist for therapeutic development or drug repurposing. For instance, existing agents like anifrolumab (an IFNAR-blocking antibody approved for lupus) could be explored in combination with CPIs. Conversely, AAbs that impair treatment point to pathways that should be preserved or enhanced, such as BMP receptor signaling. More broadly, the “autoantibody-wide association study” framework introduced here could be applied across diseases to uncover functional roles of humoral autoreactivity, much as genome-wide association studies have done for genetic variation. Larger cohorts and prospective clinical trials will be needed to confirm causal relationships and translate these findings into improved patient stratification and combination treatment strategies.
.
